TEDA BIOMEDICAL (08189) recommends adopting the 2025 stock incentive plan.
Tianda Biotech (08189) announced that on April 25, 2025, the board of directors decided to adopt the 2025 Stock...
TEDA BIOMEDICAL (08189) announced that on April 25, 2025, the board of directors decided to adopt the 2025 share incentive plan and will implement it in accordance with the revised Chapter 23 of the GEM Listing Rules, which took effect on January 1, 2023. The plan must be approved by the company's shareholders at the upcoming general meeting before it can be implemented.
Related Articles
US Stock Market Move | Withdrawal of experimental drug riluzole application in the EU market leads to a 21% drop in Biohaven (BHVN.US) stock.
US Stock Market Move | Bitcoin breaks through $95,000, and the concept stocks of cryptocurrencies continue to rise.
MARKETINGFORCE(02556): AI-driven performance growth ESG builds long-term value moats.
US Stock Market Move | Withdrawal of experimental drug riluzole application in the EU market leads to a 21% drop in Biohaven (BHVN.US) stock.
US Stock Market Move | Bitcoin breaks through $95,000, and the concept stocks of cryptocurrencies continue to rise.
MARKETINGFORCE(02556): AI-driven performance growth ESG builds long-term value moats.
RECOMMEND
Pan Gongsheng: Will implement a moderately loose monetary policy to promote high-quality development of the Chinese economy.
25/04/2025
Canadian Prime Minister Trudeau: No rush to reach agreement with Trump, US side eventually needs to face reality.
25/04/2025
Alphabet (GOOG.US, GOOGL.US) first quarter revenue and profits exceed expectations, driven by AI and cloud computing performance growth.
25/04/2025
